Letrozole significantly improves growth potential in a pubertal boy with growth hormone deficiency

Pediatrics. 2005 Feb;115(2):e245-8. doi: 10.1542/peds.2004-1536. Epub 2005 Jan 14.

Abstract

Clinical experience with using an aromatase inhibitor to suppress estrogen production during puberty for improvement of growth potential in adolescents with short stature is limited. This report documents treatment of such a patient with a combination of growth hormone and letrozole, a third-generation aromatase inhibitor. Our case demonstrates a favorable outcome on a short-term basis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Aromatase Inhibitors / therapeutic use*
  • Biomarkers / blood
  • Bone Density
  • Drug Therapy, Combination
  • Growth Disorders / blood
  • Growth Disorders / drug therapy*
  • Human Growth Hormone / deficiency*
  • Human Growth Hormone / therapeutic use
  • Humans
  • Insulin-Like Growth Factor I / analysis
  • Letrozole
  • Lipids / blood
  • Male
  • Nitriles / therapeutic use*
  • Testosterone / blood
  • Triazoles / therapeutic use*

Substances

  • Aromatase Inhibitors
  • Biomarkers
  • Lipids
  • Nitriles
  • Triazoles
  • Human Growth Hormone
  • Testosterone
  • Insulin-Like Growth Factor I
  • Letrozole